About Digi.Bio
Digi.Bio is revolutionizing the development of therapies with its AI-driven, lab-on-a-chip platform. Designed for high-content, real-time analysis, the technology enables dynamic monitoring of therapy performance at single-cell resolution. With BSL-2 laboratories at Leiden Bio Science Park and its headquarters in Amsterdam, Digi.Bio provides a digital, single-cell representation of therapy responses, offering unprecedented spatial and temporal insights into treatment behavior.
Founded in 2017 by Bharath Bynagari, Federico Muffatto, Frido Emans and Jelmer Cnossen.
- Founded
- 2017
- Employees
- 1 to 10
- Total funding
- $296K
- Headquarters
- Netherlands
Leadership
The top of Digi.Bio's org chart, with how many people report into each leader.
FM
Federico Muffatto
Founder and CEO
Jobs at Digi.Bio
No open positions right now. Explore more companies on TheJobsMap.